Indonesia

11 Vaccines Approved for Use in Indonesia

Protein Subunit

Serum Institute of India

COVOVAX (Novavax formulation)

Approved in 5 countries
3 trials in 1 country
Approval Source: reuters.com
Protein Subunit

Anhui Zhifei Longcom

Zifivax

Approved in 4 countries
20 trials in 5 countries
Approval Source: reuters.com
RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
Approval Source: reuters.com
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Approval Source: reuters.com
Non Replicating Viral Vector

CanSino

Convidecia

Approved in 10 countries
13 trials in 6 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Gamaleya

Sputnik V

Approved in 74 countries
24 trials in 7 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Janssen (Johnson & Johnson)

Ad26.COV2.S

Approved in 111 countries
23 trials in 23 countries
Approval Source: reuters.com
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries
Approval Source: reuters.com
Inactivated

Shenzhen Kangtai Biological Products Co

KCONVAC

Approved in 2 countries
7 trials in 1 country
Approval Source: barrons.com
Inactivated

Sinopharm (Beijing)

Covilo

Approved in 91 countries
30 trials in 12 countries
Approval Source: reuters.com
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Approval Source: reuters.com

13 in Clinical Trials in Indonesia

Protein Subunit

Anhui Zhifei Longcom

Zifivax

Approved in 4 countries
20 trials in 5 countries
Protein Subunit

West China Hospital

Recombinant (Sf9 cell)

7 trials in 4 countries
RNA

Walvax

mRNA

4 trials in 3 countries
Non Replicating Viral Vector

ReiThera

GRAd-COV2

5 trials in 12 countries
Inactivated

Sinovac

CoronaVac

Approved in 56 countries
37 trials in 9 countries
Protein Subunit

Adimmune Corporation

AdimrSC-2f

3 trials in 2 countries
Protein Subunit

PT Bio Farma

SARS-CoV-2 Protein Subunit Recombinant Vaccine

4 trials in 1 country
Replicating Viral Vector

Aivita Biomedical Inc

AV-COVID-19

4 trials in 2 countries
Inactivated

Airlangga University

UNAIR Inactivated COVID-19 Vaccine

2 trials in 1 country
Protein Subunit

PT Bio Farma

SARS-CoV-2 Protein Subunit Recombinant Vaccine Adjuvanted With Alum+CpG 1018

RNA

Moderna

Spikevax

Approved in 86 countries
67 trials in 23 countries
RNA

Pfizer/BioNTech

Comirnaty

Approved in 146 countries
84 trials in 27 countries
Non Replicating Viral Vector

Oxford/AstraZeneca

Vaxzevria

Approved in 140 countries
64 trials in 31 countries